Vrabie Camelia Doina, Petrescu Angela, Waller Maria, Cojocaru M, Ciocâlteu Alex, Dina I
Victor Babeş National Institute for Pathology and Biomedical Sciences, Bucharest.
Rom J Intern Med. 2009;47(2):149-59.
No other medical field but nephrology showed so important achievements as a result of concerted efforts of doctors, biologists and technicians. Considering that in renal insufficiency, regardless of its aetiology, the common path is represented by the transitory or definite damage of the "renal filter", many attempts have been made in order to reproduce the process of blood cleaning by the kidney.
The high prevalence of cardiovascular diseases in hemodialysed population suggested that the disease could begin before or during the stage of chronic renal insufficiency. We investigated the vascular lesions, especially the immunologic features of patients involved in hemodialysis programs. Our study reflects a general picture of the immunologic status of hemodialysed patients, helping to understand the special profile ofa hemodialysed patient.
Two groups have been selected and analyzed: one of 15 patients from the Hemodialysis Department in "Sfântul Ioan" Hospital, and another one composed of 30 patients with other diseases (the control group), from the Medical Department. The detection of specific antibodies against some HCV proteins corresponding to the most conserved regions of the viral genome has been done using the immune test LiaTEK HCV III. In the hemodialysed group, a blood sample has been drawn before and after the hemodialysis session, at 15-20 minutes, while in the other group the blood sample has been drawn together with the other tests. A flow cytometry examination was made at the Center of Immunology, in order to determine simultaneously several physical and chemical parameters. We analyzed the two groups of patients (HD/n=15; the reference group/n=30) regarding immunophenotyping, all types of lymphocytes and interleukin 2 (IL-2).
The results have classified the HD patients into three subgroups, depending on the mean of the results from flow cytometry exam, referred to normal values. The assessment of the patients with or without HD to each group was made on the basis of the similar behavior of the markers investigated. The most affected age group in patients with HD was 31-40 years, followed by the age group 41-50 years (26%). The majority patients of the control group were of the same age 31-40 years old (40%), while 33% of them were between 41 and 50 years old. One subgroup (A) of HD patients showed the improvement of the total number of T lymphocytes (CD3+/CD19-) after the session, while the total number of B lymphocytes was stable. The number ofT lymphocytes with receptors for interleukin 2 (CD25) improved after hemodialysis. The second group (B) presented from the beginning a low number of total T lymphocytes (CD3+/CD19-). We found that the value of B lymphocytes (CD19+/CD3-) decreased after hemodialysis. Activated T lymphocytes (CD25), with receptors for interleukin 2, achieved greater values (3.66%), which cannot be found in the other groups. The third group (C) showed normal values for total T lymphocytes (CD3+/CD19-) before HD, which did not modify significantly after the session. The patients had the same decreased values for B lymphocytes, which have continued to decrease after the HD (7.98%).
Post dialytic immunologic changes of the mononuclear cells represent the hallmark of the complexity of the immune response generally and especially too, in hemodialysed patients. We have noticed patients that presented an increase of the total number of T lymphocytes after the dialysis, but only T and NK lymphocytes and not B lymphocytes as well, suggesting the susceptibility to infections. The evaluation of the immune response using flow cytometry has confirmed the presence of high variations of the immune profile in hemodialysed patients, the decrease of T-cells activation but, it does not support the data regarding intrinsic functions of T and B cells. The high diversity of the immune response in hemodialysed patients is a consequence of the genetic individuality of each patient and also of the associated pathology or equipment used (viral infection, membrane type).
除肾脏病学外,没有其他医学领域因医生、生物学家和技术人员的共同努力而取得如此重大的成就。鉴于在肾功能不全中,无论其病因如何,共同的途径都表现为“肾滤器”的暂时或确定损伤,人们已经进行了许多尝试来重现肾脏的血液净化过程。
血液透析人群中心血管疾病的高患病率表明,该疾病可能在慢性肾功能不全阶段之前或期间就已开始。我们研究了血管病变,特别是参与血液透析项目患者的免疫特征。我们的研究反映了血液透析患者免疫状态的总体情况,有助于了解血液透析患者的特殊情况。
选择并分析了两组:一组是来自“Sfântul Ioan”医院血液透析科的15名患者,另一组是由来自内科的30名其他疾病患者组成(对照组)。使用免疫检测LiaTEK HCV III检测针对病毒基因组最保守区域的一些丙型肝炎病毒(HCV)蛋白的特异性抗体。在血液透析组中,在血液透析 session 前和 session 后15 - 20分钟采集血样,而在另一组中,血样与其他检测一起采集。在免疫学中心进行了流式细胞术检查,以同时确定几个物理和化学参数。我们分析了两组患者(血液透析组/n = 15;参照组/n = 30)的免疫表型、所有类型的淋巴细胞和白细胞介素2(IL - 2)。
根据流式细胞术检查结果的平均值与正常值比较,将血液透析患者分为三个亚组。根据所研究标志物的相似行为对每组中有或无血液透析的患者进行评估。血液透析患者中受影响最大的年龄组是31 - 40岁,其次是41 - 50岁年龄组(26%)。对照组的大多数患者年龄相同,为31 - 40岁(40%),而其中33%在41至50岁之间。血液透析患者的一个亚组(A)在 session 后显示T淋巴细胞总数(CD3 + /CD19 - )有所改善,而B淋巴细胞总数稳定。血液透析后,具有白细胞介素2受体的T淋巴细胞(CD25)数量有所改善。第二组(B)从一开始T淋巴细胞总数(CD3 + /CD19 - )就较低。我们发现血液透析后B淋巴细胞(CD19 + /CD3 - )的值下降。具有白细胞介素2受体的活化T淋巴细胞(CD25)达到了更高的值(3.66%),这在其他组中未发现。第三组(C)在血液透析前T淋巴细胞总数(CD3 + /CD19 - )显示正常值,session 后没有明显变化。患者B淋巴细胞的值同样下降,血液透析后继续下降(7.98%)。
单核细胞的透析后免疫变化代表了一般免疫反应复杂性尤其是血液透析患者免疫反应复杂性的标志。我们注意到一些患者在透析后T淋巴细胞总数增加,但仅T和NK淋巴细胞增加,B淋巴细胞未增加,这表明其易感染。使用流式细胞术评估免疫反应证实了血液透析患者免疫谱存在高度变化,T细胞活化降低,但不支持关于T和B细胞内在功能的数据。血液透析患者免疫反应的高度多样性是每个患者遗传个体性以及相关病理或所用设备(病毒感染、膜类型)的结果。